Skip to content
UniqueBaseEN
For AI ↗
Companies

Converge Bio

Visit website ↗
Snapshot

As of Oct 16, 2026, UniqueBase lists 2 funding records for Converge Bio; the latest is $25M (Series A) on Jan 13, 2026.

Funding records
2
Latest round
$25M · Series A
Total raised (reported)
—
Rows with a source link
0 of 2

Overview

Life sciences AI model platform for biotechnology and drug design

Funding · 2

Funding

Amounts as reported; USD estimates shown only when they match

Listed 2 funding records. Latest funding: $25M (Series A), Jan 13, 2026.

Annual trendUnit: USD
20242026$25MNov 20, 2024: $5.5M · SeedJan 13, 2026: $25M · Series A
DateAmountInvestorsSources
Jan 13, 2026$25M · Series ABessemer Venture Partners, Vintage Investment Partners No source link
Nov 20, 2024$5.5M · SeedTLV Partners No source link

Select ▸ on a row to see its source brief and links.

Valuation · 2

Valuation

Amounts as reported; USD estimates shown only when they match

Listed 2 valuation records.

Annual trendUnit: USD

No chartable valuation estimates yet.

2 listed records lack a clear date or positive USD estimate for the chart.

DateAmountInvestorsSources
Jan 13, 2026— · Series ABessemer Venture Partners, Vintage Investment Partners No source link
Nov 20, 2024— · SeedTLV Partners No source link

Select ▸ on a row to see its source brief and links.

Revenue

Revenue

Amounts as reported; USD estimates shown only when they match

No revenue records are listed yet.

No revenue rows to list.

Team, products & investors

Sources · 0

Sources & provenance

English text is maintained separately from the original record. Consult the original source before citing a fact.

No source links are available for this profile.

Original source text

Names may use phonetic renderings when no English name is supplied. The original wording is retained below.

面向生物技术及药物设计的生命科学 AI 模型平台